A recent development in treating pancreatic cancer offers new hope. After extensive research, an innovative experimental drug has emerged, taken once a day. This drug is showing effectiveness in prolonging the lives of patients.
By focusing on slowing the progression of pancreatic cancer, which is known for its low survival rates, this drug could change the outlook for many individuals diagnosed with the disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, contributes insights to the ongoing efforts in combating this cancer.
In an interview with Stephanie Sy, PBS News Hour correspondent, Dr. Shroff discusses the implications of this breakthrough. Stephanie Sy, a seasoned journalist, has extensive experience with PBS News Hour, Al Jazeera America, CNN International, and other major news outlets. Her reporting has covered significant events, including the 2018 Midterm Elections and providing live reports from key political moments.
Public Health Challenges with Proposed Vaccination Order 
Senator Roger Marshall Criticizes Dr. Anthony Fauci Over Vaccine Text Messages 
Understanding Medicare Extra Help and Its Benefits 
Trump’s Remarks on Childhood Vaccines Spark Debate 
CDC Reports Drug-Resistant Fungus Candida Auris Cases Across 27 States 
Medicaid Coverage and Its Impact on Pediatric Care